Michael Gelband’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
Other funds holding HAE
Michael Gelband's HAE Position: Q3 2026 in Review
Michael Gelband opened a new position in Haemonetics (HAE) in Q3 2026: 563,064 shares worth $59.3M. The stake represents 0.31% of the portfolio and ranks #46 among its holdings. This is a return to the name: Michael Gelband previously reported a position in HAE as recently as Q1 2026.
Michael Gelband first reported a position in HAE in Q4 2019 and has held it in 18 quarters since. 361 funds tracked by Wall St. Rank hold HAE as of Q3 2026.
- Michael Gelband held 563,064 shares of Haemonetics worth $59.3M as of Q3 2026.
- Haemonetics was a new Michael Gelband position in Q3 2026.
- Haemonetics made up 0.31% of Michael Gelband's portfolio in Q3 2026, its #46 holding.
- Michael Gelband first reported a position in Haemonetics in Q4 2019 and has held it in 18 quarters since.
- 361 funds tracked by Wall St. Rank held Haemonetics as of Q3 2026.
Based on ExodusPoint Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.